Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (91-100 of 511) with videos related to

Pageof 52
Sort By:
Clinical and Translational Gastroenterology|February 8, 2020
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein ThrombosisMichael Praktiknjo, Jonel Trebicka, Roberto Carnevale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosisJörg Heller, Jonel Trebicka, Thomas Shiozawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate ImmunityJinyang Zeng-Brouwers, Lisa Sophie Huber, Rosetta Merline, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2026
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver FailureCamilla Cadoli, Volker Müller, Christoph Welsch, et al.
Trials|April 24, 2023
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosisThomas Reiberger, Annalisa Berzigotti, Jonel Trebicka, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Polish Journal of Radiology|February 27, 2019
AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal veinDaniel Kuetting, Karsten Wolter, Julian Luetkens, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shuntJonel Trebicka, Aleksander Krag, Stefan Gansweid, et al.
International Journal of Molecular Sciences|October 13, 2021
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic ImplicationsWolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 27, 2023
Role of endoscopy in hepatologyWim Laleman, Kai-Henrik Peiffer, Michael Tischendorf, et al.
Pageof 52

Showing results (91-100 of 511) with videos related to

Sort By:
Pageof 52
Clinical and Translational Gastroenterology|February 8, 2020
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein ThrombosisMichael Praktiknjo, Jonel Trebicka, Roberto Carnevale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosisJörg Heller, Jonel Trebicka, Thomas Shiozawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate ImmunityJinyang Zeng-Brouwers, Lisa Sophie Huber, Rosetta Merline, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2026
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver FailureCamilla Cadoli, Volker Müller, Christoph Welsch, et al.
Trials|April 24, 2023
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosisThomas Reiberger, Annalisa Berzigotti, Jonel Trebicka, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Polish Journal of Radiology|February 27, 2019
AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal veinDaniel Kuetting, Karsten Wolter, Julian Luetkens, et al.
European Journal of Gastroenterology & Hepatology|October 6, 2011
Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shuntJonel Trebicka, Aleksander Krag, Stefan Gansweid, et al.
International Journal of Molecular Sciences|October 13, 2021
Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic ImplicationsWolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 27, 2023
Role of endoscopy in hepatologyWim Laleman, Kai-Henrik Peiffer, Michael Tischendorf, et al.
Pageof 52